MEDS 8-K
DataMeds AI, Inc. (MEDS)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of principal executive offices, including zip code)
Registrant’s
telephone number, including area code:
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| The
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Director Resignations
On February 1, 2026, Steven Lee advised the Company that he was resigning from his position as a member of the board of directors effective immediately. Mr. Lee indicated that his decision to resign was not a result of his of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices. At the time of his resignation, Mr. Lee served on the Ethics Committee.
On February 1, 2026, Howard Doss advised the Company that he was resigning from his position as a member of the board of directors effective immediately. Mr. Doss indicated that his decision to resign was not a result of his of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices. At the time of his resignation, Mr. Doss served as chairman on the Audit Committee.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
The following exhibits are filed as part of, or incorporated by reference into, this Report.
| Exhibit No. | Description | |
| 17.1 | Director Resignation Letter of Steven Lee dated as of February 1, 2026 | |
| 17.2 | Director Resignation Letter of Howard Doss dated as of February 1, 2026 | |
| 104* | Cover Page Interactive Data File (formatted as Inline XBRL) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: February 5, 2026 | WELLGISTICS HEALTH, INC. | |
| By: | /s/ Prashant Patel | |
| Prashant Patel, President | ||
Exhibit 17.1
Board Resignation
VIA EMAIL
WELLGISTICS HEALTH, INC.
3000 Bayport Drive
Suite 950
Tampa, FL 33607
Re: Resignation from the Board of Directors
Dear Mr. Ajjarapu, Chairman of the Board:
As discussed, I hereby resign from my position as a member of the Board of Directors (the “Board”) of Wellgistics Health, Inc, (the” Company”) and from any committees of the Board on which I serve, including the Governance Committee, effective immediately.
My resignation is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.
I appreciate the opportunity to have served the Company, and I am grateful to my fellow directors and the management team for their time and collaboration.
Please confirm receipt of this resignation.
Sincerely,
Steven D. Lee
Cc: Members of the Board, Management, and Legal Counsel
Exhibit 17.2
DELIVERED VIA EMAIL
February 1, 2026
Wellgistics Health, Inc.
3000 Bayport Drive, Suite 950
Tampa, FL 33607
Re: Resignation from Board of Directors and Committees
Dear Mr. Ajjarapu, Chairman of the Board:
I hereby resign from the Board of Directors of Wellgistics Health, Inc., and from the Audit and Compensation Committees of the Board, effective immediately.
My resignation is not the result of any disagreement with the Company on any matter relating to its operations, policies, or practices.
I appreciate the opportunity to have served the Company and value the professionalism and dedication of my fellow directors and the management team.
Please confirm receipt of this resignation.
Best Regards,
Howard Doss
Cc: Board Members, Management and Legal Counsel